thiazolidines has been researched along with Disease Exacerbation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kaya, D; Kitade, M; Kitagawa, K; Mitoro, A; Moriya, K; Nakanishi, K; Namisaki, T; Noguchi, R; Ozutsumi, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Tsuji, Y; Yoshiji, H | 1 |
| Chen, D; He, Y; Lin, Z; Zhang, Y | 1 |
| Alessandrini, G; Buglioni, S; D'Aguanno, S; Del Bufalo, D; Desideri, M; Di Martile, M; Gabellini, C; Pallocca, M; Trisciuoglio, D; Tupone, MG | 1 |
| Hamasaki, T; Imazu, M; Ito, S; Kitakaze, M; Nakano, A | 1 |
| de Lima Ferreira, LP; de Melo Rêgo, MJB; de Moraes Gomes, PAT; de Siqueira, LRP; Leite, ACL | 1 |
| Chen, Y; Dai, F; Gao, D; He, Y; Li, J; Liu, M; Yang, F; Yi, Z; Zhang, T | 1 |
| Bassett, K; Carleton, B; Carney, G; Dormuth, CR; Wright, JM | 1 |
| Assouly, P; Kluger, N | 1 |
| Fukuda, M; Hotta, N; Kawamori, R; Shigeta, Y | 1 |
| Baba, M | 1 |
| Barak, Y; Cormier, RT; Matise, I; McAlpine, CA | 1 |
| Brown, LA; Guidot, DM; Otis, JS | 1 |
| Alonso-Varona, A; Bilbao, P; Calle, Y; Castro, B; del Olmo, M; Palomares, T | 1 |
2 review(s) available for thiazolidines and Disease Exacerbation
| Article | Year |
|---|---|
Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Disease Progression; Drug Delivery Systems; Drug Discovery; Humans; Intracellular Signaling Peptides and Proteins; Neoplasms; Thiazoles; Thiazolidines; Thiosemicarbazones | 2019 |
[Pseudopelade of Brocq].
Topics: Adrenal Cortex Hormones; Alopecia Areata; Dermoscopy; Diagnosis, Differential; Disease Progression; Hair Follicle; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus; Lupus Erythematosus, Cutaneous; Thiazolidines | 2011 |
1 trial(s) available for thiazolidines and Disease Exacerbation
| Article | Year |
|---|---|
Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Female; Heart Failure; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Pyrazoles; Randomized Controlled Trials as Topic; Thiazolidines; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2019 |
10 other study(ies) available for thiazolidines and Disease Exacerbation
| Article | Year |
|---|---|
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Topics: Animals; Cadherins; Canagliflozin; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytokines; Disease Progression; DNA Damage; Drug Synergism; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Lipid Peroxidation; Liver Cirrhosis; Liver Neoplasms; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Pyrazoles; Rats; Rats, Inbred Strains; Thiazolidines; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2020 |
CY-09 attenuates the progression of osteoarthritis via inhibiting NLRP3 inflammasome-mediated pyroptosis.
Topics: Animals; Cartilage; Chondrocytes; Disease Models, Animal; Disease Progression; Extracellular Matrix; Female; Homeostasis; Inflammasomes; Inflammation; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Osteoarthritis; Protective Agents; Pyroptosis; Thiazolidines; Thiones; Tumor Necrosis Factor-alpha | 2021 |
BCL-X
Topics: Animals; bcl-X Protein; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mice; Mice, Nude; Nanog Homeobox Protein; Neoplastic Stem Cells; Neovascularization, Pathologic; Octamer Transcription Factor-3; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; SOXB1 Transcription Factors; Thiazolidines; Xenograft Model Antitumor Assays | 2017 |
Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Neoplasm Invasiveness; Promoter Regions, Genetic; Thiazolidines; Vorinostat | 2015 |
Thiazolidinediones and fractures in men and women.
Topics: Adult; Aged; British Columbia; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Female; Fractures, Spontaneous; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Proportional Hazards Models; Prospective Studies; Risk; Rosiglitazone; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones; Thiazolidines | 2009 |
Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neurop
Topics: Aged; Aged, 80 and over; Aldehyde Reductase; Asian People; Blood Glucose; Cost-Benefit Analysis; Diabetic Neuropathies; Diabetic Retinopathy; Disease Progression; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Multivariate Analysis; Neural Conduction; Rhodanine; Severity of Illness Index; Thiazolidines; Time Factors; Treatment Outcome | 2012 |
[Recent advances in treatment of diabetic polyneuropathy].
Topics: Anticonvulsants; Antidepressive Agents; Blood Glucose; Diabetic Neuropathies; Disease Progression; Humans; Pain; Rhodanine; Sensation Disorders; Thiazolidines | 2012 |
Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice.
Topics: Animals; Colonic Neoplasms; Disease Progression; Female; Genes, APC; Genotype; Immunohistochemistry; Intestinal Neoplasms; Male; Mice; Mice, Knockout; Phenotype; PPAR gamma; Sex Factors; Thiazoles; Thiazolidines | 2006 |
Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats.
Topics: Alcoholism; Animals; Antioxidants; Biomarkers; Central Nervous System Depressants; Disease Models, Animal; Disease Progression; Ethanol; Glutathione; Male; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Muscular Diseases; Oxidants; Oxidation-Reduction; Oxidative Stress; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; RNA, Messenger; SKP Cullin F-Box Protein Ligases; Thiazolidines; Transforming Growth Factor beta1; Up-Regulation | 2007 |
Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
Topics: Acrolein; Alkylation; Animals; Antineoplastic Agents, Alkylating; Biotransformation; Cell Division; Cyclophosphamide; Cysteine; Disease Progression; Drug Interactions; Drug Screening Assays, Antitumor; Female; Glutathione; Leukopenia; Liver Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Prodrugs; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 2000 |